What are the type of osteoporosis?
Two categories of osteoporosis have been identified: primary and secondary. Primary osteoporosis is the most common form of the disease and includes postmenopausal osteoporosis (type I), and senile osteoporosis (type II). Secondary osteoporosis is characterized as having a clearly definable etiologic mechanism.
What is Type 1 and Type 2 osteoporosis?
Postmenopausal osteoporosis (type 1) occurs in women within 15–20 years after menopause and is thought to result from factors related to or exacerbated by estrogen deficiency. Age-related osteoporosis (type 2) occurs in men and women over 75 years of age and may be more directly related to the aging process.
What causes Type 2 osteoporosis?
Type II osteoporosis (also known as senile), commonly caused by a long term calcium deficiency. Women are twice as more likely than men to suffer from Type II osteoporosis. Type II osteoporosis results in loss of the outer bone structure and also the inner trabecular bone to wear down and become thin.
What is primary osteoporosis?
Primary osteoporosis, as defined by bone loss associated with significant fracture, is most commonly caused in children by one or other of the forms of osteogenesis imperfecta (OI). These are a group of disorders that are characterised by abnormalities in type I collagen synthesis or processing.
Who osteoporosis classification?
Osteoporosis has been operationally defined on the basis of bone mineral density (BMD) assessment. According to the WHO criteria, osteoporosis is defined as a BMD that lies 2.5 standard deviations or more below the average value for young healthy women (a T-score of <-2.5 SD) (1,6).
What are the grades of osteoporosis?
The result is your T score. A T score of -1 to +1 is considered normal bone density. A T score of -1 to -2.5 indicates osteopenia (low bone density). A T score of -2.5 or lower is bone density low enough to be categorized as osteoporosis.
What’s the difference between osteoporosis and osteoarthritis?
If you have osteoporosis, your bones become weak and brittle, causing you to be at greater risk for bone fractures. Osteoarthritis is the most common type of arthritis, which is inflammation and deterioration of your joints. Osteoarthritis is the result of every day wear and tear, and is most common in older adults.
Which hormone is responsible for osteoporosis?
Parathyroid hormone (PTH) is an important contributor to the bone remodeling process. High levels of PTH can activate osteoclasts and cause excessive bone breakdown. Calcium in your blood triggers the release of PTH.
What is secondary osteoporosis?
Secondary osteoporosis is defined as bone loss that results from specific, well-defined clinical disorders. Many times reversible, secondary causes of bone loss are not considered in a patient with low bone mineral density (BMD).
What BMD means?
A bone mineral density (BMD) test measures how much calcium and other types of minerals are in an area of your bone. This test helps your health care provider detect osteoporosis and predict your risk for bone fractures.
What is the most common type of osteoporosis?
However, scientists need to carry out more research to confirm these findings. Glucocorticoid-induced osteoporosis is the most common type osteoporosis that develops due to medication use. Certain alterations to lifestyle can reduce the risk of osteoporosis.
What is the life expectancy of a person with osteoporosis?
Despite reports that people with osteoporosis have an increased risk of dying prematurely, a new study has found that life expectancy of newly diagnosed and treated osteoporosis patients is in excess of 15 years in women below the age of 75 and in men below the age of 60.
What are the 5 stages of osteoporosis?
Stage 1 occurs around age 30 to 35,when the breakdown of bone occurs at the same rate the body builds bone.
What is the best and safest treatment for osteoporosis?
Combination Drug Therapy May Be Best Treatment For Osteoporosis. The combination, which included teriparatide, a bone-building (anabolic) drug, and denosumab, a targeted therapy to stop bone loss, also increased BMD better than previously reported with any available treatment in postmenopausal women with osteoporosis.